Global Breast Tomosynthesis Market Trends

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Breast Tomosynthesis Market Size, Share, and Trends Analysis Report Trends

  • Medical Devices
  • Aug 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

“Technological Advancements Driving Accuracy and Early Detection”

  • A significant and accelerating trend in the global breast tomosynthesis market is the continual advancement in imaging technology, including higher-resolution detectors, synthetic 2D imaging, and AI-enhanced interpretation tools. These innovations are significantly improving diagnostic accuracy and workflow efficiency for radiologists and healthcare providers
    • For instance, Hologic’s Genius 3D Mammography system offers superior cancer detection rates and fewer false positives compared to traditional 2D mammography, enhancing both patient outcomes and clinician confidence. Similarly, GE Healthcare’s SenoClair tomosynthesis system provides a low-dose 3D imaging option that improves lesion visibility in dense breast tissue
  • AI integration in breast tomosynthesis systems enables intelligent image analysis, prioritization of cases, and assistance in identifying early-stage tumors. Tools such as iCAD’s ProFound AI are being used to enhance clinical decision-making by providing real-time insights during image review
  • The integration of tomosynthesis with PACS (Picture Archiving and Communication Systems) and EMRs (Electronic Medical Records) also supports centralized imaging workflows, enabling seamless data management and collaborative diagnostics. These innovations are particularly impactful in busy hospital and diagnostic settings where quick turnaround is critical
  • This trend toward more accurate, AI-powered, and digitally integrated imaging systems is fundamentally transforming breast cancer diagnostics. As a result, companies are increasingly investing in next-generation tomosynthesis platforms that promise lower radiation, faster scanning, and enhanced detection—making advanced screening accessible to a broader population
  • The growing demand for systems that offer greater precision, efficiency, and patient comfort is driving rapid adoption across hospitals, diagnostic centers, and mobile screening units, reinforcing breast tomosynthesis as a standard for modern breast imaging